Satsuma Pharmaceuticals

$0.00 (0.00%) As of 12:00 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STSA and other ETFs, options, and stocks.

About STSA

Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine.

CEO
John A. Kollins
Employees
21
Headquarters
San Francisco, California
Founded
2016

STSA Key Statistics

Market cap
107.26M
Price-Earnings ratio
—
Dividend yield
—
Average volume
48.03K
High today
$3.63
Low today
$3.02
Open price
$3.37
Volume
11.98K
52 Week high
$7.48
52 Week low
$2.51

STSA Earnings

-$0.72
-$0.48
-$0.24
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.49 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure